SCHEMBL8360878

SCHEMBL8360878

Cc1ccc(N2CCC=C(N3CCCCC3)C2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ ALDH1A1 P00352 6/20 0.42
▸ MAPT P10636 4/20 0.40
▸ RECQL P46063 1/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ PKM P14618 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CNR2 P34972 2/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ DGAT1 O75907 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8357983 0.98 ALDH1A1 (0.41) DRD2DRD3ALDH1A1MAPTRECQL
SCHEMBL17576245 0.85 AKR1C3 (0.44) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL5447292 0.85 MEN1 (0.38) ALDH1A1MAPTRECQLMEN1KMT2A
SCHEMBL5441070 0.83 MEN1 (0.36) ALDH1A1MAPTRECQLMEN1KMT2A
SCHEMBL20050092 0.82 ALDH1A1 (0.42) ALDH1A1MAPTRECQLMEN1KMT2A
SCHEMBL17205684 0.75 HPGD (0.48) ALDH1A1MEN1KMT2AL3MBTL1TSHR
SCHEMBL17205569 0.75 MAPT (0.56) ALDH1A1MAPTRECQLKMT2ALMNA
SCHEMBL19185131 0.74 NPC1 (0.41) DRD2DRD3ALDH1A1MAPTMEN1
SCHEMBL5444324 0.72 ALDH1A1 (0.48) ALDH1A1KMT2AL3MBTL1KDM4ETSHR
SCHEMBL15731795 0.72 PIK3R1 (0.39) ALDH1A1MAPTRECQLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027186-A1 SYNTHESIS OF 4,5-DIHYDRO-PYRAZOLO[3,4-C]PYRID-2-ONES BRISTOL-MYERS SQUIBB COMPANY 2007-02-01 — — US disclosed
WO-2003049681-A2 SYNTHESIS OF 4,5-DIHYDRO-PYRAZOLO [3,4-C] PYRID-2-ONES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-06-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027186-A1 SYNTHESIS OF 4,5-DIHYDRO-PYRAZOLO[3,4-C]PYRID-2-ONES F2, TFPI, TFPI2 DRD2 2665/4885DRD3 2696/4885ALDH1A1 1809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback